The relationship between sleep disturbance and pulmonary function in stable pediatric cystic fibrosis patients

Raouf Amin1, Judy Bean, Kathleen Burklow

  • 1Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, USA. aminr0@chmcc.org

Chest
|September 16, 2005
PubMed

Insights

Pediatric patients with cystic fibrosis (CF) experience lower sleep efficiency and more nighttime awakenings than healthy children. Sleep quality significantly impacts lung function (FEV1) in CF patients, indicating a two-way relationship.

Area of Science:

  • Pulmonary Medicine
  • Sleep Science
  • Pediatric Health

Background:

  • Cystic fibrosis (CF) is a common inherited disorder affecting northern European populations.
  • CF leads to progressive pulmonary and gastrointestinal symptoms, impacting daily life.
  • Understanding factors affecting CF progression is crucial for patient management.

Purpose of the Study:

  • To compare sleep efficiency in pediatric CF patients versus healthy controls.
  • To investigate the association between sleep efficiency and pulmonary function in CF.
  • To explore the bidirectional relationship between sleep and lung health in CF.

Main Methods:

  • Actigraphy recordings over 5 days for 44 CF patients and 40 controls.
  • Sleep questionnaires completed by participants and parents.
  • Pulmonary function tests (including FEV1) for CF patients.
  • Multiple regression analysis to assess correlations.

Main Results:

  • CF patients exhibited significantly lower sleep efficiency than controls.
  • FEV1 correlated positively with sleep duration and efficiency.
  • FEV1 was negatively associated with nocturnal awakenings, age, and BMI.
  • Sleep efficiency, BMI percentile, and gender predicted FEV1.
  • Nocturnal cough frequency independently predicted FEV1.

Conclusions:

  • Clinically stable pediatric CF patients have impaired sleep quality compared to healthy peers.
  • A significant, bidirectional correlation exists between sleep parameters and FEV1 in CF.
  • Sleep disturbances may influence CF lung disease progression, and vice versa.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History